-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OBLinh/G+oD3UO/ula19cO2inJy7KjA87PuAaCIQtiuCG0gQRRSJduvrICV3Uk0S Bw5z9Xe0JB5s0Ebd2UGV1w== 0001237899-10-000047.txt : 20101220 0001237899-10-000047.hdr.sgml : 20101220 20101220165957 ACCESSION NUMBER: 0001237899-10-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101217 FILED AS OF DATE: 20101220 DATE AS OF CHANGE: 20101220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWN MICHAEL S CENTRAL INDEX KEY: 0001174475 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 101263444 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-12-17 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001174475 BROWN MICHAEL S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2010-12-17 4 M 0 5000 18.8 A 34662 D Common Stock 2010-12-17 4 F 0 2897 32.44 D 31765 D Common Stock 2010-12-20 4 S 0 100 32.89 D 31665 D Common Stock 2010-12-20 4 S 0 2003 33.24 D 29662 D Non-Qualified Stock Option (right to buy) 18.8 2010-12-17 4 M 0 5000 D 2013-01-02 Common Stock 5000 5000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The reporting person sold 2,003 shares of Company stock on December 20, 2010 at prices ranging from $33.00 to $33.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2010 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. /s/**Michael S. Brown 2010-12-20 -----END PRIVACY-ENHANCED MESSAGE-----